DXR NASDAQ
Daxor Corporation
1W: -6.4%
1M: -1.1%
3M: -0.4%
YTD: -28.9%
1Y: +2.1%
3Y: +5.4%
5Y: -5.6%
$10.65
+0.44 (+4.31%)
Weekly Expected Move ±5.8%
$9
$10
$10
$11
$12
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Bullish
75
Insider+$0.0M
Congress—
ETF Holdings—
Key Statistics
Market Cap$62.2M
52W Range8.56-14.76
Volume2,375
Avg Volume4,395
Beta0.26
Dividend$0.06
Analyst Ratings
Company Info
CEOMichael Richard Feldschuh
Employees37
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date1983-07-25
Websitedaxor.com
109 Meco Lane
Oak Ridge, TN 37830
US
Oak Ridge, TN 37830
US
12123308500
About Daxor Corporation
Based in Oak Ridge, Tennessee, Daxor Corporation is a medical technology enterprise founded in 1971. The company specializes in blood volume measurement, developing and commercializing the BVA-100 Blood Volume Analyzer. This diagnostic instrument offers a precise, objective method for quantifying a patient's blood volume status and composition, comparing these metrics against their unique physiological norms. It is utilized across a wide spectrum of medical and surgical contexts. Prior to May 1973, the organization operated under the name Idant Corporation.
Latest News
Daxor reports FY results
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee
Daxor Corporation Announces Transition To Securities Exchange Act of 1934 Reporting Company, Reaffirming Focus on Core Blood Volume Analysis and Diagnostic Business
Daxor Corporation Announces $9 Million Registered Direct Offering
Daxor (NASDAQ:DXR) Trading Down 1.4% – Here’s Why
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Michel Robert J | A-Award | 12,000 | — | 2026-06-23 |
| Feldschuh Michael Ri | A-Award | 30,000 | — | 2026-06-23 |
| Feldschuh Jonathan A | A-Award | 25,000 | — | 2026-06-23 |
| Goudie Joy S. | A-Award | 2,500 | $10.14 | 2026-06-23 |
| Cremisi Henry D. | A-Award | 2,500 | $10.14 | 2026-06-23 |